An Open-Label, Randomized Phase 3 Study to Evaluate Enfortumab Vedotin vs. Chemotherapy in Subjects with Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)

Gurney, Howard (Primary Chief Investigator)
Cunningham, Jacob (Research Coordinator)
Butala, Radhika (Research Coordinator)

Faculty of Medicine, Health and Human Sciences

Project: Other

Short title	7465-CL-0301
Status	Finished
Effective start/end date	15/09/18 → 8/06/23